GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a major focus in medical research, largely due to its remarkable impact on managing diseases such as type 2 diabetes and excess body fat. New trials have demonstrated that in addition to glucose control, GLP-1 medications offer benefits for circulatory well-being and eve